Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Timeliness and completeness of routine childhood vaccinations in children by two years of age in Alberta, Canada.

Saini V, MacDonald SE, McNeil DA, McDonald SW, Kellner JD, Edwards SA, Stagg V, Tough S.

Can J Public Health. 2017 Jun 16;108(2):e124-e128. doi: 10.17269/cjph.108.5885.

PMID:
28621647
2.

Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children.

Bettinger JA, Vanderkooi OG, Scheifele DW, Halperin SA, Kellner JD, Schryvers A, De Serres G, Alcantara J.

Pediatr Infect Dis J. 2016 Nov;35(11):1242-1246.

PMID:
27753770
3.

Influence of Childhood Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Adults With Underlying Comorbidities in Calgary, Alberta (2000-2013).

Cabaj JL, Nettel-Aguirre A, MacDonald J, Vanderkooi OG, Kellner JD.

Clin Infect Dis. 2016 Jun 15;62(12):1521-6. doi: 10.1093/cid/ciw175. Epub 2016 Apr 22.

PMID:
27105745
4.

Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children.

Rajapakse NS, Vayalumkal JV, Vanderkooi OG, Ricketson LJ, Kellner JD.

Paediatr Child Health. 2016 Mar;21(2):65-6. No abstract available.

5.

Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012.

Bettinger JA, Rouleau I, Gariepy MC, Bowie WR, Valiquette L, Vanderkooi OG, Kellner JD, Coleman BL, McNeil SA, McCarthy A, De Serres G; Public Health Agency of Canada/Canadian Institutes for Health Research Influenza Research Network.

Euro Surveill. 2015 Jul 23;20(29):21189.

6.
7.

Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age.

Stearns JC, Davidson CJ, McKeon S, Whelan FJ, Fontes ME, Schryvers AB, Bowdish DM, Kellner JD, Surette MG.

ISME J. 2015 May;9(5):1268. doi: 10.1038/ismej.2015.49. No abstract available.

8.

Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age.

Stearns JC, Davidson CJ, McKeon S, Whelan FJ, Fontes ME, Schryvers AB, Bowdish DM, Kellner JD, Surette MG.

ISME J. 2015 May;9(5):1246-59. doi: 10.1038/ismej.2014.250. Epub 2015 Jan 9. Erratum in: ISME J. 2015 May;9(5):1268.

9.

Rapid online identification of adverse events after influenza immunization in children by PCIRN's National Ambulatory Network.

Bettinger JA, Vanderkooi OG, MacDonald J, Kellner JD.

Pediatr Infect Dis J. 2014 Oct;33(10):1060-4. doi: 10.1097/INF.0000000000000373.

PMID:
25361187
10.

Effectiveness of the standard and an alternative set of Streptococcus pneumoniae multi locus sequence typing primers.

Adamiak P, Vanderkooi OG, Kellner JD, Schryvers AB, Bettinger JA, Alcantara J.

BMC Microbiol. 2014 Jun 3;14:143. doi: 10.1186/1471-2180-14-143.

11.

Clinical features and outcomes of serotype 19A invasive pneumococcal disease in Calgary, Alberta.

Ricketson LJ, Vanderkooi OG, Wood ML, Leal J, Kellner JD.

Can J Infect Dis Med Microbiol. 2014 Mar;25(2):e71-5.

12.

Trends in asymptomatic nasopharyngeal colonization with streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada.

Ricketson LJ, Wood ML, Vanderkooi OG, MacDonald JC, Martin IE, Demczuk WH, Kellner JD; Calgary Streptococcus pneumoniae Epidemiology Research (CASPER) investigators.

Pediatr Infect Dis J. 2014 Jul;33(7):724-30. doi: 10.1097/INF.0000000000000267.

PMID:
24463806
13.

Factors influencing early and late mortality in adults with invasive pneumococcal disease in Calgary, Canada: a prospective surveillance study.

Ricketson LJ, Nettel-Aguirre A, Vanderkooi OG, Laupland KB, Kellner JD.

PLoS One. 2013 Oct 8;8(10):e71924. doi: 10.1371/journal.pone.0071924. eCollection 2013.

14.

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group.

PLoS Med. 2013;10(9):e1001517. doi: 10.1371/journal.pmed.1001517. Epub 2013 Sep 24.

15.

Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.

Leal J, Vanderkooi OG, Church DL, Macdonald J, Tyrrell GJ, Kellner JD.

Pediatr Infect Dis J. 2012 Sep;31(9):e169-75.

PMID:
22673137
16.

Staphylococcus aureus bloodstream infections in children: A population-based assessment.

Vanderkooi OG, Gregson DB, Kellner JD, Laupland KB.

Paediatr Child Health. 2011 May;16(5):276-80.

17.

Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: interim analysis.

Bettinger JA, Scheifele DW, Halperin SA, Kellner JD, Vanderkooi OG, Schryvers A, De Serres G, Alcantara J.

Vaccine. 2012 Jun 8;30(27):4023-7. doi: 10.1016/j.vaccine.2012.04.034. Epub 2012 Apr 23.

PMID:
22537988
18.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, Dobson S, Kellner JD, Kuhn S, Kollman T, MacKinnon-Cameron D, Smith B, Li Y, Halperin SA.

Vaccine. 2012 May 14;30(23):3389-94. doi: 10.1016/j.vaccine.2012.03.046. Epub 2012 Mar 30.

PMID:
22469860
19.

Update on the success of the pneumococcal conjugate vaccine.

Kellner J.

Paediatr Child Health. 2011 Apr;16(4):233-40. English, French.

20.

Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada.

Vanderkooi OG, Church DL, MacDonald J, Zucol F, Kellner JD.

PLoS One. 2011;6(12):e28547. doi: 10.1371/journal.pone.0028547. Epub 2011 Dec 27.

Supplemental Content

Loading ...
Support Center